HIGHLIGHTS
- who: Davide Pirolli from the InstitutUniversity of have published the paper: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface, in the Journal: Scientific Reports Scientific Reports
- what: Starting from these results and aware to transitioning to an era of endemicity with SARS-CoV-2 research, in this work the authors purpose a computational strategy for predicting if the therapeutic agents identified for past variants may continue to be useful against new ones.
- how: To investigate the performance of the computational protocol . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.